Kim Sung-wuk, CEO and president of Hanall BioPharma (formerly Hanall Pharm) donated 45,300 shares from his own stocks to employees, which accounted 1.13 percent of his total stock, or 230 million won.
Kim said that his decision to donate his shares is to boost the morale of employees and commemorate the change of the company name.
Hanall is a top 10 Korean-based R&D pharmaceutical company...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.